Israel's Therapix gets positive Tourette's drug trial results

JERUSALEM (Reuters) - Israel's Therapix Biosciences announced positive results on Monday from a Phase IIa trial of its cannabinoid-based drug to treat Tourette syndrome (TS), sending its stock price jumping.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news